Milan, Italy

Franco Maria Spreafico

This inventor holds 1 USPTO granted patent. Top assignee: Gruppa Lepetit S.p.a.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franco Maria Spreafico. Retrieved from https://idiyas.com/inventor/franco-maria-spreafico

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franco Maria Spreafico: Innovator in Antibiotic Development

Introduction

Franco Maria Spreafico is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His work focuses on addressing bacterial and fungal infections, which are critical challenges in both human and veterinary medicine.

Latest Patents

Franco Maria Spreafico holds a patent for the antibiotic GE1655 complex. This invention includes its factors, namely antibiotic GE1655 factor A, factor B, and factor C. The patent outlines the pharmaceutical acceptable salts and compositions of these antibiotics, emphasizing their use as medicaments against bacteria and fungi. This innovation is particularly aimed at treating fungal infections in both animals and humans.

Career Highlights

Throughout his career, Franco has been associated with Gruppa Lepetit S.p.a., where he has contributed to various research and development projects. His expertise in antibiotic formulation has positioned him as a key player in the pharmaceutical industry.

Collaborations

Franco has worked alongside talented colleagues such as Ernesto Riva and Graziella Beretta. Their collaborative efforts have further advanced the research and development of effective antibiotic treatments.

Conclusion

Franco Maria Spreafico's contributions to antibiotic development highlight his commitment to improving health outcomes through innovative solutions. His work continues to impact the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…